Parexel International Corp (PRXL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among several others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Waltham, Massachusetts, the US.

Parexel International Corp (PRXL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

3
List of Tables 5
List of Figures 5
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Parexel International Corp, Medical Devices Deals, 2011 to YTD 2017 10
Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Parexel International Corp, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Pamplona Capital Management Acquires Parexel International for USD5 Billion 12
Partnerships 14
Parexel Enters into Agreement with Osaka International Cancer 14
InDex Pharma Enters into Agreement with Parexel 15
Polus Enters into Agreement with Parexel 16
Parexel International Enters Into Agreement With National Taiwan University Hospital 17
Merck Enters Into An Agreement With PAREXEL International 18
Debt Offering 19
Parexel International Completes Private Placement Of Notes Due 2020 For US$100 Million 19
Acquisition 20
Parexel International Acquires Medical Affairs Company 20
Parexel International Acquires Quantum Solutions, Contract Research Organization 21
Parexel Acquires ClinIntel 22
Parexel International Acquires Atlas Medical, Contract Research Organization 23
Parexel Acquires Heron Group, Life Sciences Consultancy, For US$38.2 Million 24
Parexel International Acquires Liquent, Provider Of Regulatory Information Management Solutions, For US$72 Million 25
Parexel International Corp - Key Competitors 26
Parexel International Corp - Key Employees 27
Parexel International Corp - Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 33
Strategy And Business Planning 33
Jun 30, 2016: PAREXEL International Outlines Growth Strategy and Updates Financial Guidance at Investor Day 33
Financial Announcements 34
Aug 28, 2017: PAREXEL International Reports Fourth Quarter and Fiscal Year 2017 Results 34
May 03, 2017: PAREXEL International Reports Third Quarter Fiscal Year 2017 Results 35
Feb 01, 2017: PAREXEL International Reports Second Quarter Fiscal Year 2017 Results 37
Oct 26, 2016: PAREXEL International Reports First Quarter Fiscal Year 2017 Results and Announces New Share Repurchase Program 39
Aug 03, 2016: PAREXEL International Reports Fourth Quarter and Fiscal Year 2016 Results 40
Apr 27, 2016: PAREXEL International Reports Third Quarter Fiscal Year 2016 Results 42
Jan 27, 2016: PAREXEL International Reports Second Quarter Fiscal Year 2016 Results 43
Corporate Communications 44
Feb 28, 2017: PAREXEL International Appoints Simon Harford as Senior Vice President and Chief Financial Officer 44
Other Significant Developments 45
Sep 06, 2017: PAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments 45
Jun 19, 2017: PAREXEL Introduces Its Connected Journey of Newly Integrated Data-Driven Services to Simplify Drug Development and Commercialization 46
Oct 06, 2016: PAREXEL Launches Active Tracking Service for Monitoring and Managing Temperature-Controlled Investigational Medicinal Products 47
Jun 20, 2016: PAREXEL Experts to Discuss Key Drug Development Insights at DIA 2016 48
Feb 17, 2016: PAREXEL Launches Expanded Genomic Research Services 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50

List Of Tables

List of Tables
Parexel International Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Parexel International Corp, Deals By Therapy Area, 2011 to YTD 2017 9
Parexel International Corp, Medical Devices Deals, 2011 to YTD 2017 10
Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Pamplona Capital Management Acquires Parexel International for USD5 Billion 12
Parexel Enters into Agreement with Osaka International Cancer 14
InDex Pharma Enters into Agreement with Parexel 15
Polus Enters into Agreement with Parexel 16
Parexel International Enters Into Agreement With National Taiwan University Hospital 17
Merck Enters Into An Agreement With PAREXEL International 18
Parexel International Completes Private Placement Of Notes Due 2020 For US$100 Million 19
Parexel International Acquires Medical Affairs Company 20
Parexel International Acquires Quantum Solutions, Contract Research Organization 21
Parexel Acquires ClinIntel 22
Parexel International Acquires Atlas Medical, Contract Research Organization 23
Parexel Acquires Heron Group, Life Sciences Consultancy, For US$38.2 Million 24
Parexel International Acquires Liquent, Provider Of Regulatory Information Management Solutions, For US$72 Million 25
Parexel International Corp, Key Competitors 26
Parexel International Corp, Key Employees 27
Parexel International Corp, Other Locations 28
Parexel International Corp, Subsidiaries 29

Parexel International Corp (PRXL) - Financial and Strategic SWOT Analysis Review

Parexel International Corp (PRXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

PAREXEL International Corporation - Strategy, SWOT and Corporate Finance Report

PAREXEL International Corporation - Strategy, SWOT and Corporate Finance ReportPAREXEL International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report

USD 175 View Report

Navistar International Corp (NAV) - Financial and Strategic SWOT Analysis Review

Navistar International Corp (NAV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125 View Report

Posco International Corp (047050) - Financial and Strategic SWOT Analysis Review

Posco International Corp (047050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available